Skip to main content

Advertisement

SpringerLink
Log in

Effekt einer adjuvanten Zoledronat-Therapie bei Mammakarzinom weiterhin unklar

Efficacy of adjuvant zoledronic acid in breast cancer therapy remains unclear

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Beadle BM, Woodward WA, Buchholz TA (2011) The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 21:26–34

    Article  PubMed  Google Scholar 

  2. Coleman RE, Marshall H, Cameron D et al (2011) Breast-cancer adjuvant therapy with zoledronic acid. N Engl J Med 365:1396–1405 [Epub 2011 Sep 25]

    Article  PubMed  CAS  Google Scholar 

  3. Gnant M, Mlineritsch B, Stoeger H et al (2011) Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial. Lancet Oncol 12:631–641

    Article  PubMed  CAS  Google Scholar 

  4. Yan T, Yin W, Zhou Q et al (2012) The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials. Eur J Cancer 48:187–195

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Radioonkologie und Strahlentherapie, Städtisches Klinikum Karlsruhe, Moltkestr. 90, 76133, Karlsruhe, Deutschland

    M.-L. Sautter-Bihl

Authors
  1. M.-L. Sautter-Bihl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M.-L. Sautter-Bihl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sautter-Bihl, ML. Effekt einer adjuvanten Zoledronat-Therapie bei Mammakarzinom weiterhin unklar. Strahlenther Onkol 188, 712–713 (2012). https://doi.org/10.1007/s00066-012-0148-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-012-0148-6

Search

Navigation